Tetracycline + Margetuximab Cmkb Interaction
Majorinteraction on record
Description
Patients receiving anthracyclines less than 4 months after stopping MARGENZA may be at increased risk of cardiac dysfunction. Avoid anthracycline-based therapy for up to 4 months after stopping MARGENZA.
Mechanism
Increased risk of cardiac dysfunction
Source: NLP:margetuximab-cmkb